COVAXIN 81% effective, offers protection against UK variant: Bharat Biotech

Last updated on Mar 04, 2021, 12:31 am
COVAXIN 81% effective, offers protection against UK variant: Bharat Biotech

Trial

Trial involved 25,800 participants across 25 sites

Findings

Adverse events occurred at low levels

Quote

Important milestone in vaccine discovery: Bharat Biotech MD

Context

Earlier, COVAXIN's emergency approval had drawn criticism

Information

Government repeatedly offered assurances on vaccine's safety, efficacy

Since the backlash, the government has repeatedly assured that COVAXIN is safe and effective. Since the vaccine uses a whole inactivated virion, the government had also pointed out that it is more likely to be effective against mutated strains of the coronavirus.

Share this timeline
iQOO Neo 5 appears in live images, design features revealed
Latest News
Latest Science News
Related Timelines
Trending Topics